(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||||||
Cash flow from continuing operating activities | 25.53%-210.92K | 57.86%-223.77K | 170.94%700.14K | 154.49%3.36M | 5.16M | -283.22K | -531.06K | -986.98K | -6.17M |
Net income from continuing operations | 45.75%-1.46M | 86.95%-633.42K | -135.86%-803.79K | -725.47%-6.92M | ---1.62M | ---2.68M | ---4.85M | --2.24M | ---838.1K |
Operating gains losses | ---- | ---- | ---- | 73.88%-86.38K | ---45.97K | --4.74K | ---21.68K | ---23.47K | ---330.68K |
Deferred tax | --0 | --0 | --0 | -200.00%-329.72K | --0 | --0 | ---1.14M | --806.48K | --329.72K |
Other non cashItems | -49.56%1.17M | -93.61%368.57K | 119.68%642.04K | 2,086.14%6.17M | --1.34M | --2.32M | --5.77M | ---3.26M | ---310.54K |
Change In working capital | -197.49%-71.23K | 114.35%41.07K | 215.12%861.9K | 190.19%4.53M | --5.49M | --73.06K | ---286.25K | ---748.71K | ---5.02M |
-Change in receivables | 158.20%16.08K | 86.44%-8.1K | 226.41%880.37K | -803.33%-806.5K | ---22.73K | ---27.64K | ---59.7K | ---696.44K | ---89.28K |
-Change in prepaid assets | -79.94%3.34K | 16.26%-5.95K | -26.90%4.95K | 199.36%5.35M | --5.33M | --16.65K | ---7.11K | --6.77K | ---5.39M |
-Change in payables and accrued expense | -207.86%-90.65K | 125.12%55.12K | 60.32%-23.42K | -103.05%-13.78K | --180.66K | --84.04K | ---219.45K | ---59.03K | --451.43K |
Cash from discontinued investing activities | |||||||||
Operating cash flow | 25.53%-210.92K | 57.86%-223.77K | 170.94%700.14K | 154.49%3.36M | --5.16M | ---283.22K | ---531.06K | ---986.98K | ---6.17M |
Investing cash flow | |||||||||
Cash flow from continuing investing activities | -49.01K | 0 | 0 | 7.47%-9M | -4.4M | 0 | -659.28K | -3.94M | -9.72M |
Net PPE purchase and sale | ---49.01K | --0 | --0 | 8.50%-9M | ---4.4M | --0 | ---659.28K | ---3.94M | ---9.83M |
Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --109.16K |
Cash from discontinued investing activities | |||||||||
Investing cash flow | ---49.01K | --0 | --0 | 7.47%-9M | ---4.4M | --0 | ---659.28K | ---3.94M | ---9.72M |
Financing cash flow | |||||||||
Cash flow from continuing financing activities | 0 | 0 | 0 | 0 | 0 | 22.12M | |||
Net common stock issuance | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --22.58M |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---467.04K |
Cash from discontinued financing activities | |||||||||
Financing cash flow | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --22.12M |
Net cash flow | |||||||||
Beginning cash position | 314.00%1.26M | 0.61%1.48M | -87.70%781.71K | --6.36M | --15.92K | --303.88K | --1.47M | --6.36M | --0 |
Current changes in cash | 8.22%-259.93K | 81.20%-223.77K | 114.22%700.14K | -190.50%-5.63M | --766.41K | ---283.22K | ---1.19M | ---4.92M | --6.22M |
Effect of exchange rate changes | --0 | --0 | --0 | -58.09%56.34K | ---618 | ---4.74K | --21.29K | --40.42K | --134.42K |
End cash Position | 6,169.83%998.16K | 314.00%1.26M | 0.61%1.48M | -87.70%781.71K | --781.71K | --15.92K | --303.88K | --1.47M | --6.36M |
Free cash from | 8.22%-259.93K | 81.20%-223.77K | 114.22%700.14K | 64.81%-5.63M | --766.41K | ---283.22K | ---1.19M | ---4.92M | ---16M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data